Somebody Had a Good Quarter!
NxStage company revenues were up 7% in Q4 of 2013 over 2012, and annual revenue was up 9% in 2013 over 2012. In the home dialysis market, revenues rose by 12%—however, the net loss per share was $0.31 in 2013 vs. 0.26 in 2012.
Read the full article » | Posted 03-07-2014
- Outset Medical Analyzed By Investors Posted 01-12-2021
- Quanta Appoints John S. Lipman as President of North America Posted 12-10-2020
- Baxter’s Theranova Dialyzer Debuts Posted 11-12-2020
- CVS Health Announces New CEO Posted 11-12-2020